A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

NCT06771245 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

606

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild-to-moderate Essential Hypertension

Interventions

DRUG: SYH9056
DRUG: Levamlodipine
DRUG: Valsartan
DRUG: SYH9056 placebo
DRUG: Levamlodipine placebo
DRUG: valsartan placebo

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.